Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis
Elias Wagner, Laura McMahon, Peter Falkai, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 142, Iss. 6, pp. 456-466
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Treatment resistance in psychiatry: state of the art and new directions
Oliver Howes, Michael E. Thase, Toby Pillinger
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 58-72
Open Access | Times Cited: 242
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 178
Drug metabolism and drug transport of the 100 most prescribed oral drugs
Ditte B. Iversen, Nanna Elman Andersen, Ann‐Cathrine Dalgård Dunvald, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 131, Iss. 5, pp. 311-324
Open Access | Times Cited: 45
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status
Suzanne Reeves, Julie Bertrand, Stephen John Obee, et al.
British Journal of Clinical Pharmacology (2023) Vol. 90, Iss. 1, pp. 135-145
Open Access | Times Cited: 31
Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery
Mahdi Malekpour, Dorsa Shekouh, Mohammad Ebrahim Safavinia, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 24
A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
Justin Faden, Leslie Citrome
Schizophrenia Research (2024) Vol. 268, pp. 265-281
Closed Access | Times Cited: 11
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo‐Facorro, Andrea de Bartolomeis, et al.
European Neuropsychopharmacology (2024) Vol. 84, pp. 35-47
Open Access | Times Cited: 8
Correlation Between Clozapine and CRP Levels in Relation to Smoking Status
Robert L. Smith, Ole A. Andreassen, John M. Kane, et al.
Acta Psychiatrica Scandinavica (2025)
Closed Access | Times Cited: 1
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis
Michele Fornaro, André F. Carvalho, Michele De Prisco, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 289-303
Closed Access | Times Cited: 41
Clozapine
Robert J. Flanagan, Samora Hunter, Stephen John Obee, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 2, pp. 131-138
Closed Access | Times Cited: 17
Sex differences in effectiveness and adverse effects of mood stabilizers and antipsychotics: A systematic review
Mete Ercis, Jorge A. Sanchez‐Ruiz, Lauren M. Webb, et al.
Journal of Affective Disorders (2024) Vol. 352, pp. 171-192
Closed Access | Times Cited: 6
Clozapine levels as a predictor for therapeutic response: A systematic review and meta‐analysis
Dan Siskind, Meghna Sharma, Mrinal Pawar, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 5, pp. 422-432
Open Access | Times Cited: 38
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
Sarah Smessaert, Johan Detraux, Siska Desplenter, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 105-123
Closed Access | Times Cited: 5
The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
Anna Mach, Anna Wnorowska, Marcin Siwek, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation
Puangpet Pansawat, Wattanapong Pansawat, Sipanut Silaket, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Shared medication coordination in a social psychiatric residence: adaptation to meet local requirements
Tina Birkeskov Axelsen, Charlotte Arp Sørensen, Anders Lindelof, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Plasma Clozapine in Treatment Refractory Schizophrenia
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Schizophrenie im Alter
Detlef Wietelmann
Geriatrie up2date (2025) Vol. 07, Iss. 02, pp. 93-112
Closed Access
Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Nicole Moschny, Gudrun Hefner, R. Grohmann, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 514-514
Open Access | Times Cited: 31
Therapeutic monitoring of plasma clozapine andN-desmethylclozapine (norclozapine): practical considerations
Robert J. Flanagan, Siobhan Gee, Sarah L. Belsey, et al.
BJPsych Advances (2023) Vol. 29, Iss. 2, pp. 92-102
Open Access | Times Cited: 12
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2024) Vol. 44, Iss. 5, pp. 492-501
Closed Access | Times Cited: 4
Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database
Masakazu Hatano, Kaho Yamada, Haruna Matsuzaki, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0287122-e0287122
Open Access | Times Cited: 10
How do smoking, vaping, and nicotine affect people with epilepsy and seizures? A scoping review protocol
Jackson A. Narrett, Waleed Khan, Melissa Funaro, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288120-e0288120
Open Access | Times Cited: 10
Exploring the Smoking-Epilepsy Nexus: a systematic review and meta-analysis of observational studies
Yerin Kang, Sieun Kim, Yunah Jung, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top